Several laboratories have reported marked
tumor inhibition when the
cytokine interleukin-10 (IL-10) is overexpressed as a transgene in a variety of
tumor cells. To identify critical effector molecules, we compared the expression of the
chemokine crg-2, the murine homolog of human inducible
protein 10 (human IP-10) in murine mammary
tumors derived from the
transplantation of six
IL-10 expressing clones of tumor cell line 66.1, parental 66.1, or 66-neo-cells. We observed increased levels of IP-10
mRNA in all IL-10-expressing
tumors examined in comparison to 66-neo. IP-10
mRNA was not detected in parental 66.1
tumors. The closely related
chemokine Mig (monokine induced by
interferon-gamma [IFN-gamma]) was also induced in all IL-10-expressing
tumors. Studies of cultured tumor cells in vitro show that mammary epithelial
tumor cells, in the absence of host elements, can express IP-10 and Mig in response to induction with either
lipopolysaccharide (LPS) or IFN-gamma alone. The combination of LPS plus IFN-gamma resulted in even greater induction of IP-10
RNA. The kinetics of induction differ somewhat for the two
chemokines, with IP-10 showing slower induction and less rapid decline. Because both Mig and IP-10 are chemotactic for tumor-infiltrating lymphocytes, we examined the presence of CD4+ and CD8+ lymphocytes in these
tumors. Consistent with the upregulation of Mig and IP-10, we saw significantly increased numbers of CD8+ cells and a lesser increase in CD4+ cells in
tumors with elevated levels of both
chemokines.